Celldex Therapeutics, Inc. Deferred Revenue
Celldex Therapeutics, Inc. (CLDX) had Deferred Revenue of $2.08 million as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2018-11-07
- 2018-09-30: Deferred Revenue $2.08M.
- 2018-06-30: Deferred Revenue $1.88M.
- 2018-03-31: Deferred Revenue $1.41M.
- 2017-12-31: Deferred Revenue $2.81M.
| Period end | Deferred Revenue |
|---|---|
| 2018-09-30 | $2.08M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.88M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.81M 10-Q · filed 2018-11-07 |
| 2017-09-30 | $3.73M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.73M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.52M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $3.75M 10-K · filed 2018-03-07 |
| 2016-09-30 | $3.92M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.17M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $4.13M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $4.37M 10-K · filed 2017-03-14 |
| 2015-09-30 | $4.69M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $4.93M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $5.12M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $5.30M 10-K/A · filed 2016-02-25 |
| 2014-09-30 | $5.46M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $5.76M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.06M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $1.17M 10-K · filed 2015-02-24 |
| 2013-09-30 | $1.24M 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |